Curasight resolves on a rights issue of up to DKK 51.2 million to accelerate its therapeutic strategy

COPENHAGEN, Denmark, Feb. 13, 2024 /PRNewswire/ — Curasight A/S “Curasight” or the “Company” – (TICKER: CURAS) has today resolved on a new issue of shares with preferential rights for the Company’s existing shareholders of up to DKK 51.2 million before transaction costs (the “Rights…